G‑proteins' role in insulin‑producing beta cell health in type 2 diabetes

G protein mediated mechanisms of beta-cell compensation and failure in type 2 diabetes

NIH-funded research Wm S. Middleton Memorial Veterans Hosp · NIH-11212804

This project looks at how a signaling protein called Gαz affects insulin-producing beta cells in people with type 2 diabetes to find ways to keep those cells working longer.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionWm S. Middleton Memorial Veterans Hosp NIH-funded
Lab location1 site (Madison, United States)
Project IDNIH-11212804 on NIH RePORTER

What this research studies

Researchers will study a signaling protein called Gαz in pancreatic beta cells using lab experiments and animal models to learn why beta cells compensate or fail in type 2 diabetes. They will measure insulin release, cell growth, survival, and the molecular signaling pathways that change when Gαz is altered. The team will test whether blocking harmful Gαz signals preserves beta-cell mass or improves function in preclinical models. Results are intended to point to targets for new drugs or therapies to protect insulin-producing cells in people with diabetes.

Who could benefit from this research

Good fit: Adults with type 2 diabetes, especially those early in the disease or showing signs of declining insulin production, would be the most likely candidates for treatments developed from this work.

Not a fit: People with long-standing type 1 diabetes who have lost most beta cells or those whose diabetes is driven mainly by insulin resistance may not benefit directly from beta-cell–focused therapies.

Why it matters

Potential benefit: Could point to new treatments that protect or restore insulin-producing beta cells and improve blood sugar control in people with type 2 diabetes.

How similar studies have performed: Previous animal and cell studies have suggested G‑proteins influence beta-cell function, but translating these findings into human treatments is still early and largely untested.

Where this research is happening

Madison, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Adult-Onset Diabetes Mellitus
Last reviewed 2026-06-10 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.